AbstractContext and aimsEverolimus was approved in 2012 for the treatment of advanced hormone-receptor-positive,...
Posté par : Mr. Cyril BOISSON, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Breast Cancer Research
AbstractBackgroundMicrosatellite instability (MSI) or mismatch‑repair deficiency (dMMR) defines a biologically...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : Digestive and Liver Disease
SummaryBackgroundThe standard of care for patients with locally advanced squamous cell anal carcinoma (SCAC) is...
Posté par : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Nom de la revue : Lancet Oncology
AbstractBackground: In RAS wild-type (WT) metastatic colorectal cancer (mCRC), preliminary data have suggested that...
Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Journal of the National Cancer Institute
AbstractPurposeThe OMET GORTEC 2014-04 trial showed prolonged survival with multisite Stereotactic Ablative Body...
Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Nom de la revue : International Journal of Radiation Oncology . Biology . Physics
AbstractPurposeImmunoscore (IS) and circulating tumor DNA (ctDNA) are two emerging technologies in improving...
Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Nom de la revue : Journal of Clinical Oncology
AbstractPurposeThe objective of this work was to establish prognostic models in stage III colon cancer (CC) on the basis...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : Journal of Clinical Oncology
AbstractPurposeThe randomized phase II GORTEC 2014–04 and French Head and Neck Intergroup study showed deeper...
Posté par : Mr. Antoine FALCOZ, Mme. Aurélia MEURISSE
Nom de la revue : Radiotherapy and Oncology
ABSTRACTBackground Althoughthe benefit of supportive care in the postcancer period is now welldemonstrated, its...
Posté par : Dr. Sophie PAGET-BAILLY
Nom de la revue : Supportive & Palliative Care